» Articles » PMID: 26001553

U.S. Compounding Pharmacy-Related Outbreaks, 2001-2013: Public Health and Patient Safety Lessons Learned

Overview
Journal J Patient Saf
Specialty Health Services
Date 2015 May 24
PMID 26001553
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Pharmacy-compounded sterile preparations (P-CSPs) are frequently relied upon in U.S. health care but are increasingly being linked to outbreaks of infections. We provide an updated overview of outbreak burden and characteristics, identify drivers of P-CSP demand, and discuss public health and patient safety lessons learned to help inform prevention.

Methods: Outbreaks of infections linked to contaminated P-CSPs that occurred between January 1, 2001, and December 31, 2013, were identified from internal Centers for Disease Control and Prevention reports, Food and Drug Administration drug safety communications, and published literature.

Results: We identified 19 outbreaks linked to P-CSPs, resulting in at least 1000 cases, including deaths. Outbreaks were reported across two-thirds of states, with almost one-half (8/19) involving cases in more than 1 state. Almost one-half of outbreaks were linked to injectable steroids (5/19) and intraocular bevacizumab (3/19). Non-patient-specific compounding originating from nonsterile ingredients and repackaging of already sterile products were the most common practices associated with P-CSP contamination. Breaches in aseptic processing and deficiencies in sterilization procedures or in sterility/endotoxin testing were consistent findings. Hospital outsourcing, preference for variations of commercially available products, commercial drug shortages, and lower prices were drivers of P-CSP demand.

Conclusions: Recognized outbreaks linked to P-CSPs have been most commonly associated with non-patient-specific repackaging and nonsterile to sterile compounding and linked to lack of adherence to sterile compounding standards. Recently enhanced regulatory oversight of compounding may improve adherence to such standards. Additional measures to limit and control these outbreaks include vigilance when outsourcing P-CSPs, scrutiny of drivers for P-CSP demand, as well as early recognition and notification of possible outbreaks.

Citing Articles

Clinical and Socioeconomic Burden of Retinal Diseases: Can Biosimilars Add Value? A Narrative Review.

Hariprasad S, Holz F, Asche C, Issa A, Mora O, Keady S Ophthalmol Ther. 2025; .

PMID: 40009268 DOI: 10.1007/s40123-025-01104-3.


Everything but the Kitchen Sink: An Analysis of Bacterial and Chemical Contaminants Found in Syringe Residue From People Who Inject Drugs.

Wildenthal J, Schwartz D, Nolan N, Zhao L, Robinson J, Jones E Open Forum Infect Dis. 2024; 11(1):ofad628.

PMID: 38179104 PMC: 10766411. DOI: 10.1093/ofid/ofad628.


Emerging therapeutic strategies for unmet need in neovascular age-related macular degeneration.

Khachigian L, Liew G, Teo K, Wong T, Mitchell P J Transl Med. 2023; 21(1):133.

PMID: 36810060 PMC: 9942398. DOI: 10.1186/s12967-023-03937-7.


Retention of Sterile Compounding Knowledge Among Pharmacy Technicians.

Davis J, Ayars C J Pharm Technol. 2021; 37(5):219-224.

PMID: 34752565 PMC: 8404747. DOI: 10.1177/87551225211032395.


Implementation and validation of an in-house combined fluorescein/media-fill test to qualify radiopharmacy operators.

Fersing C, Deshayes E, Langlet S, Calas L, Lisowski V, Kotzki P EJNMMI Radiopharm Chem. 2021; 6(1):2.

PMID: 33411035 PMC: 7790972. DOI: 10.1186/s41181-020-00117-6.


References
1.
Manchikanti L, Pampati V, Falco F, Hirsch J . Assessment of the growth of epidural injections in the medicare population from 2000 to 2011. Pain Physician. 2013; 16(4):E349-64. View

2.
Kastango E, Bradshaw B . USP chapter 797: establishing a practice standard for compounding sterile preparations in pharmacy. Am J Health Syst Pharm. 2004; 61(18):1928-38. DOI: 10.1093/ajhp/61.18.1928. View

3.
Gershman M, Kennedy D, Noble-Wang J, Kim C, Gullion J, Kacica M . Multistate outbreak of Pseudomonas fluorescens bloodstream infection after exposure to contaminated heparinized saline flush prepared by a compounding pharmacy. Clin Infect Dis. 2008; 47(11):1372-9. DOI: 10.1086/592968. View

4.
. Exophiala infection from contaminated injectable steroids prepared by a compounding pharmacy--United States, July-November 2002. MMWR Morb Mortal Wkly Rep. 2003; 51(49):1109-12. View

5.
Sunenshine R, Tan E, Terashita D, Jensen B, Kacica M, Sickbert-Bennett E . A multistate outbreak of Serratia marcescens bloodstream infection associated with contaminated intravenous magnesium sulfate from a compounding pharmacy. Clin Infect Dis. 2007; 45(5):527-33. DOI: 10.1086/520664. View